Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2022-04-01
Serie:Frontiers in Pharmacology
Ämnen:
treatment-resistant
ziprasidone
sertraline
efficacy
schizophrenia
acute exacerbation
Länkar:https://www.frontiersin.org/articles/10.3389/fphar.2022.863588/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk